US Federal Trade Commission sues to block Amgen's $28bn Horizon Therapeutics deal
Amgen
Leah Nylen
The Federal Trade Commission sued to block Amgen Inc.'s $27.8bn deal to buy Horizon Therapeutics Plc Tuesday, arguing the tie-up would stifle competition for the development of treatments for serious illnesses.